| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2016-09-30 | |
| Chairman | - | 2017-10-26 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 24.88M | ||
| -0.78% | +9.95% | +56.87% | +142.37% | 1,263B | ||
| -1.32% | +1.28% | +44.80% | +79.52% | 658B | ||
| -2.20% | +0.55% | +36.03% | +101.26% | 521B | ||
| -1.54% | +0.18% | +53.06% | +66.79% | 391B | ||
| -0.68% | +5.83% | +80.40% | +44.69% | 369B | ||
| -1.69% | +3.17% | +32.18% | +55.35% | 307B | ||
| -0.72% | +7.83% | +12.10% | +33.76% | 290B | ||
| +0.06% | +5.01% | +57.57% | +75.13% | 252B | ||
| -0.13% | +7.59% | +39.89% | +110.19% | 212B | ||
| Average | -0.88% | +5.90% | +45.88% | +78.78% | 473.55B | |
| Weighted average by Cap. | -1.05% | +6.60% | +48.52% | +93.02% |
Employees
-
Sector
Pharmaceuticals
















